TRIAL DETAIL

GDC-0449 and RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma

Drug:
Trial Name:
GDC-0449 and RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
NCT#:
Conditions:
Solid Tumors
Status:
Completed
Phase:
1
Start Date 06/01/2010
Age of Trial (yrs) 13.8
Treatment Phase:
Gleevec-resistant
Drug Category:
PTCH/SMO inhibitor + Gamma Secretase inhibitor
Strategy:
Block Hedgehog & Notch pathways
Trial Type:
Specifically GIST plus other cancers
Other Protocol IDs:
CDR0000680558, MSKCC-10049
Sponsor:
Memorial Sloan-Kettering Cancer Center, National Cancer Institute
Patient Contact:
Contact email:
Contact Phone:
Randomized:
IV or Oral:
Oral
Trial Notes:

Trial Links

Trial Results

Drug Information

Trial Sites

Name
Address
City
State
Zip
Country
1275 York Ave
New York
NY
10065
USA